“May all be happy, may all be healed, may all be at peace and may no one ever suffer."
Kawasaki disease is a rare but serious condition that primarily affects children under the age of 5. It is characterized by inflammation of the blood vessels throughout the body and can lead to serious complications if left untreated.
The exact cause of Kawasaki disease is unknown, but it is thought to be triggered by an infection or an abnormal immune response to an infection.
Symptoms of Kawasaki disease may include:
If left untreated, Kawasaki disease can lead to serious complications, such as heart disease, aneurysms, and inflammation of the heart muscle.
Treatment for Kawasaki disease typically involves a combination of medications to reduce inflammation and prevent blood clots. These may include aspirin and intravenous immunoglobulin (IVIG). In some cases, other medications such as corticosteroids or tumor necrosis factor (TNF) inhibitors may also be used.
Early diagnosis and treatment are important for preventing complications and reducing the risk of long-term heart damage. If your child develops symptoms of Kawasaki disease, seek medical attention immediately.
No one knows what causes Kawasaki disease, but scientists don't believe the disease is contagious from person to person. Some think that Kawasaki disease happens after a bacterial or viral infection, or that it's linked to other environmental factors. Certain genes might make children more likely to get Kawasaki disease.
To reduce the risk of long-term complications, your child's health care provider will want to begin treatment for Kawasaki disease as soon as possible, preferably while your child still has a fever. The goals of initial treatment are to lower fever and inflammation and prevent heart damage.
Treatment for Kawasaki disease can include:
Because of the risk of serious complications, initial treatment for Kawasaki disease is usually given in a hospital where doctors can continue to monitor the child.
Once the fever goes down, a child might need to take low-dose aspirin for at least six weeks — longer if he or she develops a coronary artery aneurysm. Aspirin helps prevent blood clotting.
However, children who develop flu or chickenpox during treatment might need to stop taking aspirin. Taking aspirin has been linked to Reye's syndrome, a rare but potentially life-threatening condition that can affect the blood, liver and brain of children and teenagers after a viral infection.
With treatment, a child might start to improve soon after the first gamma globulin treatment. Without treatment, Kawasaki disease lasts about 12 days. However, heart complications might last longer.
If your child has any signs of heart problems, the health care provider might recommend follow-up tests to check your child's heart health at regular intervals, often at 6 to 8 weeks after the illness began, and then again after six months.
If heart problems continue, your child might be referred to a doctor who specializes in treating heart disease in children (pediatric cardiologist). Treatment for heart complications related to Kawasaki disease depends on the type of heart condition.
If your child was given gamma globulin, it's a good idea to wait at least 11 months to get a live vaccine, such as the chickenpox or measles vaccine, because gamma globulin can affect how well these vaccinations work. Tell your child's health care provider that your child has had Kawasaki disease.